-
Je něco špatně v tomto záznamu ?
WAA apheresis registry in the Czech Republic: two centers experience
M. Blaha, J. Ptak, J. Cap, V. Ceeova, V. Masin, S. Filip, M. Blazek
Jazyk angličtina Země Velká Británie
Typ dokumentu multicentrická studie, práce podpořená grantem
Grantová podpora
NR9181
MZ0
CEP - Centrální evidence projektů
NR9103
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Část
Zdroj
Zdroj
- MeSH
- dospělí MeSH
- fotoferéza MeSH
- hypercholesterolemie terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- plazmaferéza metody statistika a číselné údaje škodlivé účinky MeSH
- registrace statistika a číselné údaje MeSH
- separace krevních složek metody statistika a číselné údaje škodlivé účinky MeSH
- transfuze erytrocytů MeSH
- transfuze leukocytů MeSH
- transfuze trombocytů MeSH
- trombocytaferéza MeSH
- výměna plazmy statistika a číselné údaje MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
INTRODUCTION: Hemaphereses are sophisticated procedures performed for many indications even in severely ill patients. Many authors consider quite necessary to register as many details as possible of treatments with therapeutic apheresis. WAA meets the requirement to compare data with centers not performing apheresis for the same diagnosis. In Czech Republic hemaphereses are used in a broad spectrum of indications. Since the year 2004 data on hemaphereses done in Czech Republic have been registered. In this paper we present a survey of our to date recordings. PATIENTS AND METHODS: Data of performed therapeutic hemaphereses (plasma exchange, erythrocytapheresis, leukapheresis, thrombocytapheresis, photopheresis, immunopheresis, and rheopheresis) have been entered in WAA registry with many details. We have been evaluated 1289 procedures in 216 patients done in our two centers (center I, center II). RESULTS: Center I registered 129 procedures in 41 patients, center II 1260 procedures in 175 patients. The patients are divided according to centers specialization (center II has registered 12 long-term treated patients with LDL-apheresis; mean time of therapy 7.1 years and a median of 34 procedures/patient. Side-effects registered in center I and center II were 3.1% and 5.6% of the procedures, respectively. Most frequent side-effects were citrate toxicity, neurovegetative lability, problems with venous access and hypotension. All were easy to treat, no serious events or death occurred. CONCLUSIONS: In Czech Republic hemaphereses are performed in a broad scale of indications and now it is nearly 5 years that data are registered in our two university centers. In 2004 we entered WAA registry because it meets the requirement to compare data with centers that do not perform aphereses for the same diagnosis. This comparison would certainly improve efficacy of the hemapheresis therapy even further. To enter WAA registry is easy, at no expense and without any problems.
- 000
- 03978naa a2200565 a 4500
- 001
- bmc12009174
- 003
- CZ-PrNML
- 005
- 20140407150601.0
- 008
- 120319s2009 xxk eng||
- 009
- AR
- 040 __
- $d ABA008 $a ABA008 $b cze
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Bláha, Milan, $d 1938- $7 xx0034440 $u Faculty of Medicine and Faculty Hospital, Charles University, Hradec Kralove, Czech Republic. blaha@fnhk.cz
- 245 10
- $a WAA apheresis registry in the Czech Republic: two centers experience $c M. Blaha, J. Ptak, J. Cap, V. Ceeova, V. Masin, S. Filip, M. Blazek
- 520 9_
- $a INTRODUCTION: Hemaphereses are sophisticated procedures performed for many indications even in severely ill patients. Many authors consider quite necessary to register as many details as possible of treatments with therapeutic apheresis. WAA meets the requirement to compare data with centers not performing apheresis for the same diagnosis. In Czech Republic hemaphereses are used in a broad spectrum of indications. Since the year 2004 data on hemaphereses done in Czech Republic have been registered. In this paper we present a survey of our to date recordings. PATIENTS AND METHODS: Data of performed therapeutic hemaphereses (plasma exchange, erythrocytapheresis, leukapheresis, thrombocytapheresis, photopheresis, immunopheresis, and rheopheresis) have been entered in WAA registry with many details. We have been evaluated 1289 procedures in 216 patients done in our two centers (center I, center II). RESULTS: Center I registered 129 procedures in 41 patients, center II 1260 procedures in 175 patients. The patients are divided according to centers specialization (center II has registered 12 long-term treated patients with LDL-apheresis; mean time of therapy 7.1 years and a median of 34 procedures/patient. Side-effects registered in center I and center II were 3.1% and 5.6% of the procedures, respectively. Most frequent side-effects were citrate toxicity, neurovegetative lability, problems with venous access and hypotension. All were easy to treat, no serious events or death occurred. CONCLUSIONS: In Czech Republic hemaphereses are performed in a broad scale of indications and now it is nearly 5 years that data are registered in our two university centers. In 2004 we entered WAA registry because it meets the requirement to compare data with centers that do not perform aphereses for the same diagnosis. This comparison would certainly improve efficacy of the hemapheresis therapy even further. To enter WAA registry is easy, at no expense and without any problems.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a separace krevních složek $x metody $x statistika a číselné údaje $x škodlivé účinky $7 D001781
- 650 02
- $a transfuze erytrocytů $7 D017707
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a lidé $7 D006801
- 650 02
- $a hypercholesterolemie $x terapie $7 D006937
- 650 02
- $a transfuze leukocytů $7 D017708
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a fotoferéza $7 D017893
- 650 02
- $a výměna plazmy $x statistika a číselné údaje $7 D010951
- 650 02
- $a plazmaferéza $x metody $x statistika a číselné údaje $x škodlivé účinky $7 D010956
- 650 02
- $a transfuze trombocytů $7 D017713
- 650 02
- $a trombocytaferéza $7 D010983
- 650 02
- $a registrace $x statistika a číselné údaje $7 D012042
- 650 02
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pták, Jan, $d 1950- $7 xx0034439
- 700 1_
- $a Čáp, Jan, $d 1953- $7 mzk2003190513
- 700 1_
- $a Ceeová, Věra $7 xx0142514
- 700 1_
- $a Mašín, Vladimír $7 xx0061146
- 700 1_
- $a Filip, Stanislav, $d 1961- $7 jn20010309153
- 700 1_
- $a Blažek, Martin, $d 1973- $7 xx0052609
- 773 0_
- $t Transfusion & Apheresis Science $p Transfus Apheresis Sci $g Roč. 41, č. 1 (2009), s. 27-31 $x 1473-0502 $w MED00008583
- 773 0_
- $p Transfus Apheresis Sci $g 41(1):27-31, 2009 Aug $x 1473-0502
- 910 __
- $a ABA008 $b x $y 4 $z 0
- 990 __
- $a 20120319150917 $b ABA008
- 991 __
- $a 20140407150648 $b ABA008
- 999 __
- $a ok $b bmc $g 902397 $s 766080
- BAS __
- $a 3
- BMC __
- $a 2009 $b 41 $c 1 $d 27-31 $i 1473-0502 $m Transfusion and apheresis science $x MED00008583
- GRA __
- $a NR9181 $p MZ0
- GRA __
- $a NR9103 $p MZ0
- LZP __
- $a 2012-1Q10/jj